Search results
Biogen, Beckman Coulter and Fujirebio partner to develop Alzheimer’s Tau blood test
Medical Device Network· 14 hours agoBiogen, Beckman Coulter and Fujirebio have partnered to identify and develop new blood-based...
Half Of Dementia Cases Can Be Curbed By Addressing These Key Risk Factors
NDTV· 1 hour agoMillions of cases of dementia could be prevented or delayed by reducing a range of risk factors such...
Vaccinex’s Phase Ib/II trial for Alzheimer’s treatment hits primary endpoint
Clinical Trials Arena· 12 hours agoVaccinex states a drug that can slow progression of this could significantly extend a productive...
Vertex’s pain drug gets speedy FDA review; Keytruda hits a sales milestone
BioPharma Dive· 17 hours agoQuarterly sales of Merck’s immunotherapy crested $7 billion for the first time. Elsewhere, Fibrogen...